114 related articles for article (PubMed ID: 13914979)
21. Potentiation of reactive hyperemia in the coronary and femoral circulation by the selective use of 2,6-bis(diethanolamino)-4,8-dipiperidino-pyrimodo[5,4-d]pyrimidine.
Miura M; Tominaga S; Hashimoto K
Arzneimittelforschung; 1967 Aug; 17(8):976-9. PubMed ID: 5632072
[No Abstract] [Full Text] [Related]
22. [The dose-dependent action of 2,6-bits (diethanolamino)-4, 8-dipiperidino-pyrimido(5,4-d) pyrimidine on the dynamics of the isolated, spontaneously beating heart of cold-blooded animals].
WEZLER K
Arzneimittelforschung; 1961 Oct; 11():943-56. PubMed ID: 14006417
[No Abstract] [Full Text] [Related]
23. [BIOCHEMICAL AND PHYSIOLOGIC STUDIES ON THE ANOXIC DOG HEART WITH EXTRACORPOREAL CIRCULATION WITH AND WITHOUT ADMINISTRATION OF PERSANTIN (2,6-BIS(DIETHANOLAMINO)-4,8-DIPIPERIDINO-PYRIMIDO-(5,4-D)PYRIDINE)].
EKESTROEM S; PALEUS S; ABERG T
Cardiologia (Basel); 1965; 46():281-94. PubMed ID: 14342749
[No Abstract] [Full Text] [Related]
24. [Treatment of coronary insufficiency with 2,6-bis(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d)-pyrimidine].
AGOTE POVEDA IP; VILLANUEVA EDO A; ALONSOLOMAS L; ARIAS MARTINEZ JL; SARRALDE G
Rev Clin Esp; 1960 Dec; 79():181-9. PubMed ID: 13681671
[No Abstract] [Full Text] [Related]
25. [Clinical studies on the effect of persantin (2, 6-bis (diethanolamino)-4 8-dipiperidino-pyrimido (5, 4-d) pyrimidine in angina pectoris].
HAMM J; RENSCHLER HE; ZACK WJ
Medizinische; 1959 Jan; 4(3):120-3. PubMed ID: 13643401
[No Abstract] [Full Text] [Related]
26. MODE OF ACTION OF ADENINE, URIDINE AND CYTIDINE NUCLEOTIDES AND 2,6-BIS(DIETHANOLAMINO)-4,8-DIPIPERIDINO-PYRIMIDINO(5,4-D)PYRIMIDINE ON THE CORONARY, RENAL AND FEMORAL ARTERIES.
HASHIMOTO K; KUMAKURA S; TANEMURA I
Arzneimittelforschung; 1964 Nov; 14():1252-4. PubMed ID: 14317943
[No Abstract] [Full Text] [Related]
27. [Action of 2,6-bis(diethanolamino)-4,8-dipiperidinopyrimido(5,4-d)pyrimidine on the circulation].
GEBHARDT W; DRESSEL J; STEIM H; REINDELL H
Arzneimittelforschung; 1961 Oct; 11():962-9. PubMed ID: 13897426
[No Abstract] [Full Text] [Related]
28. [The fate of 2,6-bis(diethanolamino)-4,8-dipiperidinopyrimido-(5,4-d)-pyrimidine in the human and animal organism].
BEISENHERZ G; KOSS FW; SCHUELE A; GEBAUER I; BAERISCH R; FROEDE R
Arzneimittelforschung; 1960 Apr; 10():307-12. PubMed ID: 13798353
[No Abstract] [Full Text] [Related]
29. Absorption and activity of 2,6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d) pyrimidine (RA8) following enteric administration.
Kadatz R; Beisenherz G
Arch Int Pharmacodyn Ther; 1965 Dec; 158(2):389-402. PubMed ID: 5868589
[No Abstract] [Full Text] [Related]
30. [FLUORIMETRIC DETERMINATION OF 2,6-BIS(DI(2-HYDROXYETHYL)AMINO)-4, 8-DIPIPERIDINO-PYRIMIDO(5,4-D)PYRIMIDINE IN PLASMA AND ERYTHROCYTES].
LABADIE P
Pathol Biol; 1964 Jan; 12():24-31. PubMed ID: 14133422
[No Abstract] [Full Text] [Related]
31. The absorption and excretion of 2,6-bis(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d)pyrimidine after oral administration.
Beisenherz G; Koss F; Klatt L; Binder B
Arch Int Pharmacodyn Ther; 1965 Dec; 158(2):380-8. PubMed ID: 5868588
[No Abstract] [Full Text] [Related]
32. [Hemodynamic evaluation of 2,6 bis(diethanolamino)-4,8-dipiperidino-pyrimido(5,4-d) pyrimidine in patients with Chagas' heart disease].
Montenegro CI; Kuschnir E; Corcoba C
Prensa Med Argent; 1965 Jul; 52(27):1649-55. PubMed ID: 4955205
[No Abstract] [Full Text] [Related]
33. [Fuctional analytical studies on the effect of 2,6-bis(diethanolamino)-4,8-dipiperidinopyrimido(5,4-d)pyrimidine on the lung].
REESCHUCH K; ULMER WT
Arzneimittelforschung; 1963 Jan; 13():64-6. PubMed ID: 13973595
[No Abstract] [Full Text] [Related]
34. [Temperature and fever reducing properties of 2,6-bis(diethanolamino)--4,8-dipiperidino-pyrimido(5,4-d)pyrimidine (dipyridamol) in rabbits].
Haan J; Penzhorn H
Arzneimittelforschung; 1968 Jun; 18(6):752-5. PubMed ID: 5755814
[No Abstract] [Full Text] [Related]
35. [STUDY OF THE PROTECTIVE EFFECT OF A PYRIMIDO-PYRIMIDINE DERIVATIVE (PERSANTIN) ON EXPERIMENTAL ANOXIA OF THE MYOCARDIUM IN THE RAT].
DUBOISTESSELIN R
Therapie; 1964; 19():1291-6. PubMed ID: 14227792
[No Abstract] [Full Text] [Related]
36. [ON THE MECHANISM OF ACTION OF 2,6-BIS(DIETHANOLAMINO)-4,8-DIPIPERIDINOPYRIMIDO(5,4-D)PYRIMIDINE ON MYOCARDIAL CIRCULATION].
BETZ E; BENZING H
Arzneimittelforschung; 1963 Aug; 13():702-6. PubMed ID: 14085924
[No Abstract] [Full Text] [Related]
37. [Angiocoronariographic evaluation of a new coronary vasodilator: 2,6-bis(diethanolamino)-4,8-dipiperidino-pirimido-(5,4-D)pyrimidine].
CORELL LLOPIS R; ZARAGOZA PUELLES R; HUESO JULIA E; SERNA TORIJA JL; MONGAY MARTIN R
Rev Clin Esp; 1962 Aug; 86():208-20. PubMed ID: 14023020
[No Abstract] [Full Text] [Related]
38. [STUDIES ON THE PROLONGATION AND SURVIVAL TIME OF ISOLATED RABBIT HEART AFTER PRELIMINARY TREATMENT WITH 2,6-BIS-(DIETHANOLAMINO)-4,8-DIPIPERIDNOPYRIMIDO(5,4-D)PYRIMIDINE].
HOELSCHER B
Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1964 Nov; 308():886-90. PubMed ID: 14348622
[No Abstract] [Full Text] [Related]
39. [Clinical experiences and experimental studies on a new pyrimido-pyrimidine derivative].
KNIPPING HW; BOLT W; MIKULICZ K
Arzneimittelforschung; 1960 May; 10():364-9. PubMed ID: 14410137
[No Abstract] [Full Text] [Related]
40. [Effect of serum proteins on the inhibition of adenosine permeability of human- and canine-erythrocyte membranes by 2,6-bis(diethanolamino)-4,8-dipiperidino-pyrimido-5,4-d-pyrimidine].
Kopitar Z
Arzneimittelforschung; 1970 Feb; 20(2):253-5. PubMed ID: 5467472
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
